SIG SAUER - Never Settle

Posts Tagged ‘Keeogo’

B-TEMIA Initiates Pivotal Clinical Trial To Support Commercial Launch Of Keeogo In The U.S.

Tuesday, November 24th, 2015

– Partnering with three of the most reputable rehab centers in North America –

Quebec, November 23, 2015 – B-TEMIA Inc., the market leader in human augmentation, today announced that it has initiated a multi-centre pivotal clinical trial, aimed at demonstrating the superior clinical benefits and safety for home use of its powered assistive DemoskeletonTM technology, called Keeogo, for patients suffering from reduced mobility due to their medical conditions. Led by Principal Investigator, Dr. Chris A. McGibbon, PhD, from the University of New Brunswick’s, Faculty of Kinesiology and Institute of Biomedical Engineering, the study is expected to generate the required data to support the submission of a 510(k) pre-market notification to the U.S. Food and Drug Administration in 2016, a prerequisite to start commercialization in the United States.

“This is the first international clinical trial involving the DermoskeletonTM technology that aims at demonstrating the efficacy and safety of Keeogo™ during everyday community and home mobility use, something that has not been possible in the past with other exoskeleton technologies that were developed principally for use in a clinical rehabilitation setting,” stated Dr. Chris A. McGibbon.

As part of the trial, B-TEMIA has partnered with three of the most reputable rehabilitation institutions in North America: the Rehabilitation Institute of Chicago, the Spaulding Rehabilitation Hospital Boston, and the Toronto Rehabilitation Institute–UHN.

“This pivotal clinical trial will be key in supporting the commercial launch of KeeogoTM in the U.S. market. Based on earlier very positive pilot studies, we are confident that it will demonstrate how Keeogo™ could significantly improve the daily activities of those who suffer from disabilities that impact their mobility,” said Mr. Stéphane Bédard, President & CEO of B-TEMIA.

B-TEMIA Announces A Medical Breakthrough For Individuals With Limited Walking Endurance

Wednesday, May 14th, 2014

A while back, we wrote about a company called B-TEMIA, who received funding from Revision Eyewear to develop a dermoskeleton mechanism to assist soldiers suffering from musculoskeletal injuries. Recently, B-TEMIA has announced Keeogo, a commercial motorized walking assistive device that was likely developed from that same technology.

Quebec, May 13, 2014 – B-TEMIA Inc. announces today the first public unveiling of Keeogo™ at the Canadian Seating Mobility & More Conference in Toronto.


Keeogo™ is a motorized walking assistive device worn on the lower body that provides individuals with the leg power they need to walk more, better and keep on going throughout their day. Keeogo™ is designed for individuals who have limited walking endurance or mobility issues resulting of muscle weakness, aging in general or due to a number of medical conditions including Multiple Sclerosis, Parkinson’s disease or a cardiovascular condition such as peripheral artery diseases.

“Regaining autonomy in mobility is so critical to an individual’s health and well being. We are excited to unveil Keeogo™ and look forward to helping many Canadians.” comments Mr. Stéphane Bédard, President and CEO of B-TEMIA.

Keeogo™ is being demonstrated this week at booth 103 at the Canadian Seating Mobility & More Conference in Toronto.